These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22141433)

  • 1. Increasing access to the MDR-TB surveillance programme through a collaborative model in western Kenya.
    Park PH; Magut C; Gardner A; O'yiengo DO; Kamle L; Langat BK; Buziba NG; Carter EJ
    Trop Med Int Health; 2012 Mar; 17(3):374-9. PubMed ID: 22141433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation.
    Mpagama SG; Mbelele PM; Chongolo AM; Lekule IA; Lyimo JJ; Kibiki GS; Heysell SK
    BMC Public Health; 2019 Apr; 19(1):395. PubMed ID: 30971228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scale-up of multidrug-resistant tuberculosis laboratory services, Peru.
    Shin SS; Yagui M; Ascencios L; Yale G; Suarez C; Quispe N; Bonilla C; Blaya J; Taylor A; Contreras C; Cegielski P
    Emerg Infect Dis; 2008 May; 14(5):701-8. PubMed ID: 18439349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the effect of decentralisation of laboratory diagnosis for drug-resistant tuberculosis in Kenya.
    Sharma A; Musau S; Heilig CM; Okumu AO; Opiyo EO; Basiye FL; Miruka FO; Kioko JK; Sitienei JK; Cain KP
    Int J Tuberc Lung Dis; 2015 Nov; 19(11):1348-53. PubMed ID: 26467587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India.
    Shewade HD; Kokane AM; Singh AR; Verma M; Parmar M; Chauhan A; Chahar SS; Tiwari M; Khan SN; Gupta V; Tripathy JP; Nagar M; Singh SK; Mehra PK; Kumar AM
    BMC Health Serv Res; 2017 Apr; 17(1):249. PubMed ID: 28376789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China.
    Shi W; Davies Forsman L; Hu Y; Zheng X; Gao Y; Li X; Jiang W; Bruchfeld J; Diwan VK; Hoffner S; Xu B
    Int J Infect Dis; 2020 Jul; 96():390-397. PubMed ID: 32353546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey.
    Menzies HJ; Moalosi G; Anisimova V; Gammino V; Sentle C; Bachhuber MA; Bile E; Radisowa K; Kachuwaire O; Basotli J; Maribe T; Makombe R; Shepherd J; Kim B; Samandari T; El-Halabi S; Chirenda J; Cain KP
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1026-33. PubMed ID: 25189548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a rapid screening test for rifampicin resistance in re-treatment tuberculosis patients in the Eastern Cape.
    Albert H; Trollip AP; Seaman T; Abrahams C; Mole RJ; Jordaan A; Victor T; Hoosain E
    S Afr Med J; 2007 Sep; 97(9):858-63. PubMed ID: 17985057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience establishing tuberculosis laboratory capacity in a developing country setting.
    Paramasivan CN; Lee E; Kao K; Mareka M; Kubendiran G; Kumar TA; Keshavjee S; Satti H; Alabi G; Raviglione M; Roscigno G
    Int J Tuberc Lung Dis; 2010 Jan; 14(1):59-64. PubMed ID: 20003696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strengthening the Tuberculosis Specimen Referral Network in Uganda: The Role of Public-Private Partnerships.
    Joloba M; Mwangi C; Alexander H; Nadunga D; Bwanga F; Modi N; Downing R; Nabasirye A; Adatu FE; Shrivastava R; Gadde R; Nkengasong JN
    J Infect Dis; 2016 Apr; 213 Suppl 2(Suppl 2):S41-6. PubMed ID: 27025697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya.
    Ogwang MO; Imbuga M; Ngugi C; Mutharia L; Magoma G; Diero L
    BMC Infect Dis; 2021 Nov; 21(1):1175. PubMed ID: 34809602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of a new model for early detection of patients with multidrug-resistant tuberculosis in a developed setting of eastern China.
    Liu Z; Pan A; Wu B; Zhou L; He H; Meng Q; Chen S; Pang Y; Wang X
    Trop Med Int Health; 2017 Oct; 22(10):1328-1333. PubMed ID: 28746979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].
    Sezen F; Albayrak N; Özkara Ş; Karagöz A; Alp A; Duyar Ağca F; İnan Süer A; Müderris T; Ceyhan İ; Durmaz R; Ertek M;
    Mikrobiyol Bul; 2015 Apr; 49(2):143-55. PubMed ID: 26167815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
    Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
    BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug susceptibility profiles of pulmonary Mycobacterium tuberculosis isolates from patients in informal urban settlements in Nairobi, Kenya.
    Kerubo G; Amukoye E; Niemann S; Kariuki S
    BMC Infect Dis; 2016 Oct; 16(1):583. PubMed ID: 27756241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon.
    Noeske J; Voelz N; Fon E; Abena Foe JL
    BMC Res Notes; 2012 Mar; 5():160. PubMed ID: 22436423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provider reported barriers and solutions to improve testing among tuberculosis patients 'eligible for drug susceptibility test': A qualitative study from programmatic setting in India.
    Shewade HD; Kokane AM; Singh AR; Parmar M; Verma M; Desikan P; Khan SN; Kumar AMV
    PLoS One; 2018; 13(4):e0196162. PubMed ID: 29677210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDR/XDR-TB Colour Test for drug susceptibility testing of Mycobacterium tuberculosis, Northwest Ethiopia.
    Shibabaw A; Gelaw B; Kelley HV; Tesfaye E; Balada-Llasat JM; Evans CA; Torrelles JB; Wang SH; Tessema B
    Int J Infect Dis; 2020 Jan; 90():213-218. PubMed ID: 31689528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct tuberculosis drug susceptibility testing: time-saving and cost-effective in detecting MDR-TB.
    Zhang T; Lv CF; Wang J; Zheng WB; Lu LZ; Liu SJ; Bao J
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):323-8. PubMed ID: 27046712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.